Waters (NYSE:WAT) Given New $350.00 Price Target at Barclays

Waters (NYSE:WAT) had its target price reduced by Barclays from $400.00 to $350.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical instruments supplier’s stock. Barclays‘s price target indicates a potential upside of 7.55% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the company. Robert W. Baird raised Waters from a “neutral” rating to an “outperform” rating and raised their target price for the stock from $396.00 to $407.00 in a research note on Wednesday, March 26th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a research report on Friday, January 10th. JPMorgan Chase & Co. lifted their price target on shares of Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, March 6th. Bank of America decreased their price objective on shares of Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a report on Thursday, February 13th. Finally, KeyCorp upgraded shares of Waters from a “sector weight” rating to an “overweight” rating and set a $460.00 target price for the company in a report on Monday, March 31st. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Waters has an average rating of “Moderate Buy” and an average price target of $397.25.

Waters Trading Up 3.4 %

Shares of WAT stock opened at $325.44 on Thursday. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. Waters has a twelve month low of $279.24 and a twelve month high of $423.56. The company’s 50-day moving average price is $368.81 and its 200-day moving average price is $372.37. The stock has a market cap of $19.33 billion, a price-to-earnings ratio of 30.39, a PEG ratio of 3.79 and a beta of 1.04.

Waters (NYSE:WAT) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, equities analysts predict that Waters will post 12.86 earnings per share for the current year.

Institutional Trading of Waters

Several hedge funds have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd purchased a new stake in shares of Waters in the 4th quarter valued at approximately $28,000. Bank of Jackson Hole Trust purchased a new position in Waters in the fourth quarter valued at $34,000. Fortitude Family Office LLC lifted its holdings in Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 66 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its position in shares of Waters by 129.3% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 53 shares in the last quarter. Finally, Whipplewood Advisors LLC increased its holdings in shares of Waters by 5,200.0% in the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 104 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.